Variant report
Variant | nsv436926 |
---|---|
Chromosome Location | chr3:163650181-163667184 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:7)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:7 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:163647521..163649115-chr3:163652164..163654381,2 | MCF-7 | breast: | |
2 | chr3:163639924..163641654-chr3:163663861..163665823,2 | MCF-7 | breast: | |
3 | chr1:219388883..219389633-chr3:163652052..163652630,2 | MCF-7 | breast: | |
4 | chr3:163660440..163662829-chr3:163666000..163668542,2 | K562 | blood: | |
5 | chr3:163219408..163221189-chr3:163663438..163665910,2 | K562 | blood: | |
6 | chr3:163664276..163666199-chr3:163667456..163669439,2 | MCF-7 | breast: | |
7 | chr3:163660440..163662829-chr3:163666000..163668542,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs3903763 | chr3:163650181-163650182 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs11914838 | chr3:163650254-163650255 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs78989618 | chr3:163650255-163650256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs544042596 | chr3:163650289-163650290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569583249 | chr3:163650374-163650375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs538841013 | chr3:163650375-163650376 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538606708 | chr3:163650380-163650381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs377596973 | chr3:163650384-163650385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533009200 | chr3:163650397-163650398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs374820614 | chr3:163650508-163650509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs11926779 | chr3:163650527-163650528 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs560054392 | chr3:163650561-163650562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs528450280 | chr3:163650564-163650565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs148347533 | chr3:163650565-163650566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568430598 | chr3:163650712-163650713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567130707 | chr3:163650756-163650757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs193092313 | chr3:163650793-163650794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550848754 | chr3:163650849-163650850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs368022487 | chr3:163650863-163650864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs373750508 | chr3:163650888-163650889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs557662307 | chr3:163650895-163650896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540080037 | chr3:163650921-163650922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553688848 | chr3:163650926-163650927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs113772040 | chr3:163650990-163650991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs7645490 | chr3:163657804-163657805 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs577634069 | chr3:163657848-163657849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs10936378 | chr3:163657889-163657890 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs553017702 | chr3:163657912-163657913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570794659 | chr3:163657922-163657923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs572806782 | chr3:163657932-163657933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs3849461 | chr3:163657933-163657934 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs555100693 | chr3:163657969-163657970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs561670246 | chr3:163657986-163657987 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs34761378 | chr3:163658028-163658029 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs544027010 | chr3:163658074-163658075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564008556 | chr3:163658136-163658137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs182460921 | chr3:163658183-163658184 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:163646000-163650600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr3:163650600-163651000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr3:163657800-163658200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr3:163657800-163658200 | Enhancers | HUES6 Cell Line | embryonic stem cell |